Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$154.86+0.08 (+0.05%)
Close on Nov 12, 2026Market cap $20.78BP/E –Yield –
Guardant Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Guardant Health's profit margin for the twelve months ending Sep 30, 2026 was -37.9%. For fiscal 2025 it was -42.4%, against -59.0% the year before. The highest annual figure on record is -35.3% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -42.4% | +16.7 |
| FY2024 | Dec 31, 2024 | -59.0% | +26.0 |
| FY2023 | Dec 31, 2023 | -85.0% | +60.6 |
| FY2022 | Dec 31, 2022 | -145.6% | −42.6 |
| FY2021 | Dec 31, 2021 | -103.0% | −67.7 |
| FY2019 | Dec 31, 2019 | -35.3% | +58.6 |
| FY2018 | Dec 31, 2018 | -93.8% | +73.1 |
| FY2017 | Dec 31, 2017 | -167.0% | +15.8 |
| FY2016 | Dec 31, 2016 | -182.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -34.5% | +0.5 |
| Q2 FY2026 | Jun 30, 2026 | -35.9% | +7.2 |
| Q1 FY2026 | Mar 31, 2026 | -37.2% | +9.6 |
| Q4 FY2025 | Dec 31, 2025 | -45.7% | +9.3 |
| Q3 FY2025 | Sep 30, 2025 | -35.0% | +21.3 |
| Q2 FY2025 | Jun 30, 2025 | -43.0% | +14.9 |
| Q1 FY2025 | Mar 31, 2025 | -46.8% | +21.5 |
| Q4 FY2024 | Dec 31, 2024 | -55.0% | +65.6 |
| Q3 FY2024 | Sep 30, 2024 | -56.3% | +3.9 |
| Q2 FY2024 | Jun 30, 2024 | -57.9% | −4.8 |
| Q1 FY2024 | Mar 31, 2024 | -68.2% | +35.5 |
| Q4 FY2023 | Dec 31, 2023 | -120.6% | −10.4 |
| Q3 FY2023 | Sep 30, 2023 | -60.2% | +77.8 |
| Q2 FY2023 | Jun 30, 2023 | -53.1% | +157.2 |
| Q1 FY2023 | Mar 31, 2023 | -103.7% | +24.5 |
| Q4 FY2022 | Dec 31, 2022 | -110.3% | −33.9 |
| Q3 FY2022 | Sep 30, 2022 | -138.0% | −25.2 |
| Q2 FY2022 | Jun 30, 2022 | -210.2% | −134.9 |
| Q1 FY2022 | Mar 31, 2022 | -128.2% | +128.6 |
| Q4 FY2018 | Dec 31, 2018 | -76.4% | – |
| Q3 FY2018 | Sep 30, 2018 | -112.8% | – |
| Q4 FY2017 | Dec 31, 2017 | -75.3% | – |
| Q3 FY2017 | Sep 30, 2017 | -256.8% | – |
See a number that looks wrong?